This blog follows my journey on an experimental cancer treatment for relapsed Chronic Lymphocytic Leukaemia.  The two drugs ABT-199, now known as venetoclax and Obinutuzimab, previously known as Gazyva are entering phase 2 clinical trials.  Early results are exciting and I feel very lucky to be able to have the opportunity to become a human lab rat and help in their development.